EVALUATION OF SINGLE-AGENT THERAPY IN HUMAN COLORECTAL TUMOR XENOGRAFTS

被引：30
|
作者：
HOUGHTON, PJ
HOUGHTON, JA
机构：
来源：
BRITISH JOURNAL OF CANCER | 1978年 / 37卷 / 05期
关键词：
D O I：
10.1038/bjc.1978.122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：833 / 840
页数：8
相关论文
共 50 条
  • [1] EXPERIMENTAL COMBINATION AND SINGLE-AGENT CHEMOTHERAPY IN HUMAN LUNG-TUMOR XENOGRAFTS
    SHORTHOUSE, AJ
    JONES, JM
    STEEL, GG
    PECKHAM, MJ
    BRITISH JOURNAL OF CANCER, 1982, 46 (01) : 35 - 44
  • [2] SINGLE-AGENT THERAPY
    HARGER, JH
    OBSTETRICS AND GYNECOLOGY, 1983, 62 (01): : 134 - 134
  • [3] Predictive pharmacokinetic–pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts
    Maurizio Rocchetti
    Massimiliano Germani
    Francesca Del Bene
    Italo Poggesi
    Paolo Magni
    Enrico Pesenti
    Giuseppe De Nicolao
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1147 - 1157
  • [4] Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts
    Rocchetti, Maurizio
    Germani, Massimiliano
    Del Bene, Francesca
    Poggesi, Italo
    Magni, Paolo
    Pesenti, Enrico
    De Nicolao, Giuseppe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1147 - 1157
  • [5] SINGLE-AGENT PROPHYLAXIS WITH CEFOTETAN IN COLORECTAL SURGERY
    ANDREASEN, JJ
    TRIERMORCH, P
    NIELSEN, K
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (02) : 174 - 175
  • [6] SINGLE-AGENT THERAPY WITHOUT COMPLICATIONS
    不详
    CARDIOVASCULAR MEDICINE, 1985, 10 (05): : 17 - 17
  • [7] Single-agent combinatorial cancer therapy
    Stritzker, Jochen
    Szalay, Aladar A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (21) : 8325 - 8326
  • [8] Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy
    Thomas C. Wehler
    Swaantje Hamdi
    Annett Maderer
    Claudine Graf
    Ines Gockel
    Irene Schmidtmann
    Michael Hainz
    Martin R. Berger
    Matthias Theobald
    Peter R. Galle
    Markus Moehler
    Carl C. Schimanski
    International Journal of Colorectal Disease, 2013, 28 : 385 - 398
  • [9] SINGLE-AGENT THERAPY FOR HODGKINS-DISEASE
    CARTER, SK
    LIVINGSTON, RB
    ARCHIVES OF INTERNAL MEDICINE, 1973, 131 (03) : 377 - 387
  • [10] Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
    Kanikarla Marie, Preeti
    Sorokin, Alexey V.
    Bitner, Lea A.
    Aden, Rebecca
    Lam, Michael
    Manyam, Ganiraju
    Woods, Melanie N.
    Anderson, Amanda
    Capasso, Anna
    Fowlkes, Natalie
    Overman, Michael J.
    Menter, David G.
    Kopetz, Scott
    FRONTIERS IN ONCOLOGY, 2022, 12
12345